Home » Goodbye, Lipitor. Pfizer Bids a Farewell
Goodbye, Lipitor. Pfizer Bids a Farewell
Farewell after all, Lipitor. Pfizer conducted an intriguing experiment in brand marketing this year, aggressively pushing the cholesterol-fighting drug Lipitor in the U.S. even after its patent expired on Nov. 30.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May